MX2009003241A - Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d. - Google Patents
Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d.Info
- Publication number
- MX2009003241A MX2009003241A MX2009003241A MX2009003241A MX2009003241A MX 2009003241 A MX2009003241 A MX 2009003241A MX 2009003241 A MX2009003241 A MX 2009003241A MX 2009003241 A MX2009003241 A MX 2009003241A MX 2009003241 A MX2009003241 A MX 2009003241A
- Authority
- MX
- Mexico
- Prior art keywords
- dinor
- methylene
- skin
- compound
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Esta invención describe análogos de 2-metilen-(20R,25S)-19,27- dinor-(22E)-vitamina D y específicamente 2-metilen-(20R,25S)-19,27 -dinor-(22E)-1?,25-dihidroxivitamina D3 y a sus usos farmacéuticos. Este compuesto exhibe actividad pronunciada para frenar la proliferación de células no diferenciadas e inducir su diferenciación al monocito, de esta manera evidenciando el uso como un agente anti-cáncer y para el tratamiento de enfermedades de la piel tales como soriasis así como condiciones de la piel tales como arrugas, piel holgada, piel seca, e insuficiente secreción del sebo. Este compuesto también tiene poca, de haber, actividad calcémica y por lo tanto puede utilizarse para tratar desórdenes autoinmunes o enfermedades inflamatorias en humanos así como osteodistrofia renal. Este compuesto también puede utilizarse para el tratamiento o prevención de obesidad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84880306P | 2006-09-28 | 2006-09-28 | |
PCT/US2007/079384 WO2008039754A1 (en) | 2006-09-28 | 2007-09-25 | 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009003241A true MX2009003241A (es) | 2009-05-05 |
Family
ID=38860081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009003241A MX2009003241A (es) | 2006-09-28 | 2007-09-25 | Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d. |
Country Status (8)
Country | Link |
---|---|
US (1) | US7741314B2 (es) |
EP (1) | EP2069297A1 (es) |
JP (1) | JP2010504995A (es) |
AU (1) | AU2007300214A1 (es) |
CA (1) | CA2662992A1 (es) |
MX (1) | MX2009003241A (es) |
NZ (1) | NZ575111A (es) |
WO (1) | WO2008039754A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8193170B2 (en) * | 2008-07-10 | 2012-06-05 | Wisconsin Alumni Research Foundation | 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs |
US8399439B2 (en) * | 2008-07-10 | 2013-03-19 | Wisconsin Alumni Research Foundation | 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs |
JP2013506685A (ja) * | 2009-10-02 | 2013-02-28 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | (20S,22E)−2−メチレン−19−ノル−22−エン−1α,25−ジヒドロキシビタミンD3類似体 |
EP2556054B1 (en) * | 2010-03-23 | 2017-09-27 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
AU2011232633B2 (en) * | 2010-03-23 | 2014-05-29 | Wisconsin Alumni Research Foundation | (20S)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22- dimethyl-1alpha,25-hydroxyvitamin D3 |
US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
AU2012271759B2 (en) * | 2011-06-14 | 2017-02-02 | Wisconsin Alumni Research Foundation | 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses |
AU2012326485B2 (en) * | 2011-10-21 | 2016-12-08 | Wisconson Alumni Research Foundation | 2-methylene-vitamin D analogs and their uses |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486333A (en) * | 1981-04-10 | 1984-12-04 | Felix Sebba | Preparation of biliquid foam compositions |
US4666634A (en) * | 1984-12-05 | 1987-05-19 | Chugai Seiyaku Kabushiki Kaisha | vitamin D3 derivatives having a substituent at 2-position |
US5086191A (en) * | 1991-05-28 | 1992-02-04 | Wisconsin Alumni Research Foundation | Intermediates for the synthesis of 19-nor vitamin D compounds |
EP0619306B1 (en) * | 1993-04-05 | 1996-09-11 | Wisconsin Alumni Research Foundation | 19-Nor-vitamin D3 compounds with substituent at 2-position |
US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
US5945410A (en) * | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
KR100694526B1 (ko) * | 1999-04-23 | 2007-03-13 | 레오 파마 에이/에스 | 약제학적 조성물 |
DK1286962T3 (da) * | 2000-05-31 | 2008-10-06 | Wisconsin Alumni Res Found | 2-Ethyl og 2-ethyliden-19-nor-vitamin D-forbindelser |
CN1216493C (zh) | 2000-07-21 | 2005-08-24 | 皇家菲利浦电子有限公司 | 确定用户简档的方法和系统 |
US6440953B1 (en) * | 2000-09-08 | 2002-08-27 | Wisconsin Alumni Research Foundation | 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
US6627622B2 (en) * | 2002-02-18 | 2003-09-30 | Wisconsin Alumni Research Foundation | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
US6566352B1 (en) * | 2002-02-18 | 2003-05-20 | Wisconsin Alumni Research Foudation | 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
GB0305332D0 (en) | 2003-03-10 | 2003-04-09 | Leuven K U Res & Dev | Biological evaluation of novel vitamin D analogues |
US20050009792A1 (en) | 2003-07-08 | 2005-01-13 | Deluca Hector F. | (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses |
WO2005051323A2 (en) | 2003-11-25 | 2005-06-09 | Wisconsin Alumni Research Foundation | Vitamin d analogs for obesity prevention and treatment |
MX2007006263A (es) * | 2004-11-22 | 2007-07-10 | Wisconsin Alumni Res Found | Analogos 2a-metil y 2??-metil de 19,26,27-trinor-(20s)-1a- hidroxivitamina d3 y sus usos. |
EP1853274B1 (en) * | 2005-02-11 | 2013-01-23 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor- (20s-24s) - 1alpha, 25-dihydroxyvitamine-d2 |
US7528122B2 (en) | 2006-02-02 | 2009-05-05 | Wisconsin Alumni Research Foundation | Vitamin D analog—NEL, methods and uses thereof |
WO2008035207A2 (en) * | 2006-04-06 | 2008-03-27 | Wisconsin Alumni Research Foundation | 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
-
2007
- 2007-09-25 AU AU2007300214A patent/AU2007300214A1/en not_active Abandoned
- 2007-09-25 CA CA002662992A patent/CA2662992A1/en not_active Abandoned
- 2007-09-25 NZ NZ575111A patent/NZ575111A/en not_active IP Right Cessation
- 2007-09-25 JP JP2009530554A patent/JP2010504995A/ja active Pending
- 2007-09-25 WO PCT/US2007/079384 patent/WO2008039754A1/en active Application Filing
- 2007-09-25 US US11/860,870 patent/US7741314B2/en not_active Expired - Fee Related
- 2007-09-25 EP EP07843120A patent/EP2069297A1/en not_active Withdrawn
- 2007-09-25 MX MX2009003241A patent/MX2009003241A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
NZ575111A (en) | 2012-02-24 |
WO2008039754A1 (en) | 2008-04-03 |
JP2010504995A (ja) | 2010-02-18 |
EP2069297A1 (en) | 2009-06-17 |
US20080081800A1 (en) | 2008-04-03 |
US7741314B2 (en) | 2010-06-22 |
CA2662992A1 (en) | 2008-04-03 |
AU2007300214A1 (en) | 2008-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006057899A3 (en) | 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses | |
MX2007006263A (es) | Analogos 2a-metil y 2??-metil de 19,26,27-trinor-(20s)-1a- hidroxivitamina d3 y sus usos. | |
WO2006057886A3 (en) | 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES | |
WO2006057901A3 (en) | 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES | |
EP1482951B8 (en) | 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses | |
MX2009003241A (es) | Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d. | |
IL154699A0 (en) | 1alpha-HYDROXY-2-METHYLENE-19-NOR-HOMOPREGNACALCIFEROL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
WO2006057932A3 (en) | 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES | |
MX2010007264A (es) | Análogos de vitamina d 2-metilen-(20s, 25r)-19, 26-dinor. | |
MX2010007205A (es) | Analogos de vitamina d, 2-metilen-20-metil-19, 24, 25, 26, 27-pentanor. | |
MX2009002944A (es) | Analogos de 2-metilen-(20s,25s)-19,27-dinor-(22e)-vitamina d. | |
WO2010006125A3 (en) | 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs | |
WO2010006169A3 (en) | 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs | |
WO2006057902A3 (en) | 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses | |
WO2010006172A3 (en) | 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs | |
WO2009086439A3 (en) | 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs | |
WO2010006162A3 (en) | 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs | |
WO2010006135A3 (en) | 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs | |
ATE496885T1 (de) | 1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor vitamin-d-verbindungen mit einer 1,1- dimethylpropyl-seitenkette | |
WO2010006129A3 (en) | 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |